Esperion Therapeutics
ESPR
#6517
Rank
NZ$1.34 B
Marketcap
NZ$5.23
Share price
0.00%
Change (1 day)
267.19%
Change (1 year)

Earnings for Esperion Therapeutics (ESPR)

Earnings in 2025 (TTM): -NZ$49.04 Million

According to Esperion Therapeutics's latest financial reports the company's current earnings are NZ$0.30 Billion. In 2024 the company made an earning of NZ$12.53 Million, an increase over its 2023 earnings that were of -NZ$0.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Esperion Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$49.04 Million-491.31%
2024 NZ$12.53 M-104.99%
2023 -NZ$0.26 Billion-15.03%
2022 -NZ$0.3 Billion-20.61%
2021 -NZ$0.38 Billion84.28%
2020 -NZ$0.21 Billion35.75%
2019 -NZ$0.15 Billion-55.71%
2018 -NZ$0.34 Billion19.57%
2017 -NZ$0.29 Billion125.39%
2016 -NZ$0.13 Billion51.43%
2015 -NZ$82.25 Million36.45%
2014 -NZ$60.28 Million43.55%
2013 -NZ$41.99 Million145.26%
2012 -NZ$17.12 Million
2002 -NZ$48.81 Million-7.81%
2001 -NZ$52.95 Million15.03%
2000 -NZ$46.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$17.68 B-38,695.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$8.60 B-18,892.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-NZ$0.9 Billion 1,855.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-NZ$0.12 Billion 149.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ$0.31 M-100.70%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.64 B-1,505.17%๐Ÿ‡บ๐Ÿ‡ธ USA